Aramark (ARMK)
NYSE: ARMK · Real-Time Price · USD
39.65
+0.54 (1.38%)
Aug 12, 2025, 3:11 PM - Market open
Theseus Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 27, 2025 | Sep '24 Sep 27, 2024 | Sep '23 Sep 29, 2023 | Sep '22 Sep 30, 2022 | Oct '21 Oct 1, 2021 | Oct '20 Oct 2, 2020 | 2016 - 2020 |
| 17,875 | 17,401 | 16,083 | 13,687 | 12,096 | 12,830 | Upgrade | |
Revenue Growth (YoY) | 4.02% | 8.19% | 17.51% | 13.16% | -5.72% | -20.94% | Upgrade |
Cost of Revenue | 15,094 | 14,733 | 13,686 | 11,725 | 10,659 | 11,552 | Upgrade |
Gross Profit | 2,780 | 2,667 | 2,398 | 1,962 | 1,437 | 1,277 | Upgrade |
Selling, General & Admin | 1,541 | 1,534 | 1,366 | 1,181 | 856.1 | 881.02 | Upgrade |
Operating Expenses | 2,006 | 1,970 | 1,776 | 1,579 | 1,407 | 1,476 | Upgrade |
Operating Income | 774.95 | 697.51 | 621.53 | 382.84 | 30.04 | -198.82 | Upgrade |
Interest Expense | -358.68 | -389.19 | -467.29 | -384.86 | -413.71 | -368.53 | Upgrade |
Interest & Investment Income | 22.48 | 22.48 | 29.81 | 16.68 | 15.25 | 14.99 | Upgrade |
Other Non Operating Income (Expenses) | - | - | - | - | -2.9 | -8.36 | Upgrade |
EBT Excluding Unusual Items | 438.74 | 330.79 | 184.05 | 14.67 | -371.32 | -560.72 | Upgrade |
Merger & Restructuring Charges | - | - | -35.1 | -19.6 | -9 | - | Upgrade |
Impairment of Goodwill | - | - | - | - | - | -198.6 | Upgrade |
Gain (Loss) on Sale of Investments | 25.07 | 25.07 | 375.97 | - | 137.93 | - | Upgrade |
Asset Writedown | - | - | -27.2 | - | - | -30.6 | Upgrade |
Other Unusual Items | 17.87 | 9 | 65.8 | 52.15 | 109.54 | 125.9 | Upgrade |
Pretax Income | 481.68 | 364.87 | 563.52 | 47.21 | -132.85 | -647.72 | Upgrade |
Income Tax Expense | 119.8 | 102.97 | 116.43 | 8.43 | -40.63 | -186.28 | Upgrade |
Earnings From Continuing Operations | 361.88 | 261.89 | 447.1 | 38.78 | -92.22 | -461.44 | Upgrade |
Earnings From Discontinued Operations | - | - | 226.43 | 155.4 | - | - | Upgrade |
Net Income to Company | 361.88 | 261.89 | 673.53 | 194.18 | -92.22 | -461.44 | Upgrade |
Minority Interest in Earnings | -0.21 | 0.63 | 0.58 | 0.31 | 1.39 | -0.09 | Upgrade |
Net Income | 361.67 | 262.52 | 674.11 | 194.48 | -90.83 | -461.53 | Upgrade |
Net Income to Common | 361.67 | 262.52 | 674.11 | 194.48 | -90.83 | -461.53 | Upgrade |
Net Income Growth | 4.67% | -61.06% | 246.61% | - | - | - | Upgrade |
Shares Outstanding (Basic) | 264 | 263 | 261 | 257 | 255 | 252 | Upgrade |
Shares Outstanding (Diluted) | 268 | 266 | 263 | 259 | 255 | 252 | Upgrade |
Shares Change (YoY) | 0.98% | 1.37% | 1.36% | 1.70% | 1.16% | -0.07% | Upgrade |
EPS (Basic) | 1.37 | 1.00 | 2.59 | 0.76 | -0.36 | -1.83 | Upgrade |
EPS (Diluted) | 1.36 | 0.99 | 2.57 | 0.75 | -0.36 | -1.83 | Upgrade |
EPS Growth | 3.13% | -61.51% | 243.06% | - | - | - | Upgrade |
Free Cash Flow | 280.76 | 299.09 | 382.89 | 382.55 | 249.26 | -241.83 | Upgrade |
Free Cash Flow Per Share | 1.05 | 1.12 | 1.46 | 1.48 | 0.98 | -0.96 | Upgrade |
Dividend Per Share | 0.420 | 0.390 | 0.425 | 0.440 | 0.440 | 0.440 | Upgrade |
Dividend Growth | 10.53% | -8.24% | -3.41% | - | - | - | Upgrade |
Gross Margin | 15.55% | 15.33% | 14.91% | 14.33% | 11.88% | 9.96% | Upgrade |
Operating Margin | 4.33% | 4.01% | 3.86% | 2.80% | 0.25% | -1.55% | Upgrade |
Profit Margin | 2.02% | 1.51% | 4.19% | 1.42% | -0.75% | -3.60% | Upgrade |
Free Cash Flow Margin | 1.57% | 1.72% | 2.38% | 2.79% | 2.06% | -1.88% | Upgrade |
EBITDA | 1,240 | 1,133 | 1,031 | 780.82 | 580.74 | 396.38 | Upgrade |
EBITDA Margin | 6.94% | 6.51% | 6.41% | 5.71% | 4.80% | 3.09% | Upgrade |
D&A For EBITDA | 464.84 | 435.55 | 409.86 | 397.98 | 550.69 | 595.2 | Upgrade |
EBIT | 774.95 | 697.51 | 621.53 | 382.84 | 30.04 | -198.82 | Upgrade |
EBIT Margin | 4.33% | 4.01% | 3.86% | 2.80% | 0.25% | -1.55% | Upgrade |
Effective Tax Rate | 24.87% | 28.22% | 20.66% | 17.86% | - | - | Upgrade |
Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.